Category:Dihydrofolate reductase inhibitors
These agents inhibit the enzyme dihydrofolate reductase, an important rate-limiting step in the de novo folate synthesis pathway. Methotrexate is a cancer chemotherapeutic agent, whilst trimethoprim is an antibiotic. The reason for this disparity, despite both being dihydrofolate reductase inhibitors, is that methotrexate has a selective affinity for mammalian dihydrofolate reductase, while trimethoprim has a selective affinity for the bacterial enzyme.
Wikimedia Commons has media related to Dihydrofolate reductase inhibitors.
Subcategories
This category has the following 4 subcategories, out of 4 total.
Next items are not visible in browsers without Javascript
Next items are not visible in browsers without Javascript
Pages in category "Dihydrofolate reductase inhibitors"
The following 2 pages are in this category, out of 2 total.
Next items are not visible in browsers without Javascript
Next items are not visible in browsers without Javascript
This category content has been reduced to only pages contained in the ZIM file.
Category: